Pricing Log in Create free account

NKGen Biotech, Inc. (NKGN) vs Theriva Biologics, Inc. (TOVX)

NKGen Biotech, Inc. and Theriva Biologics, Inc. are both Biotechnology companies. NKGen Biotech, Inc. is the larger, with a market value of $8.8M against $7.7M — 1.1× the size. Across the 9 metrics below, Theriva Biologics, Inc. leads on 5 and NKGen Biotech, Inc. on 4.

Valuation

Metric NKGN TOVX Biotechnology median
P/E n/m n/m 10.26
P/S n/m n/m 9.18
P/B n/m 0.60 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m 0.20 0.65
EV/Sales n/m n/m 8.98
Earnings yield (10,600.00%) (430.94%) (34.89%)
Free cash flow yield (4,296.38%) (174.05%) (24.52%)

Profitability

Metric NKGN TOVX Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 44.70% (115.11%) (50.12%)
Return on assets (146.49%) (37.14%) (45.60%)
Return on invested capital 0.00% (301.72%) 0.00%

Growth

Metric NKGN TOVX Biotechnology median
Revenue growth (TTM) — — 6.26%
EPS growth (last fiscal year) 71.38% 89.07% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric NKGN TOVX Biotechnology median
Debt to equity (0.59) 0.13 0.00
Current ratio 0.05 1.13 4.89
Net debt to EBITDA (1.69) 0.48 1.01

Dividend

Metric NKGN TOVX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric NKGN TOVX Biotechnology median
Market cap 8.76m 7.73m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack